Thursday, May 02, 2024

Technology | 2007.03.29

ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel

 

For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News